-
Mixing Psychedelics And Opioids For Chronic Pain: What Are The Risks?
Saturday, September 16, 2023 - 1:31pm | 1163This article was originally published on Psychedelic Spotlight and appears here with permission. There is limited research on the combination of psychedelics and opioids. Nonetheless, a study investigating the interaction between opioids and hallucinogens found that low opioid doses tend to...
-
Harvard Doctor Shatters Taboos: 'People Can Use Cannabis Instead Of Opioids For Pain'
Saturday, September 2, 2023 - 2:22pm | 1776Via El Planteo Dr. Peter Grinspoon is a general practitioner at Harvard University, writer, medical cannabis specialist, and lecturer. In 2016 he published the book “Free Refills: A Doctor Confronts His Addiction” which seeks to explain the vulnerability of healthcare personnel to...
-
Oregon Becomes First US State To Decriminalize Drug Possession, Begins Psilocybin Program
Wednesday, November 4, 2020 - 9:43am | 705Voters in Oregon have approved two measures that mark an unprecedented change in the history of U.S. drug policy. Measure 110, which passed with 58.8% positive votes, decriminalizes the possession of small amounts of all illegal drugs. It also creates a support program for drug abuse...
-
Collegium Rallies On 'Value-Based Contract' With Cigna; Here's What It Means
Thursday, October 5, 2017 - 12:08pm | 406Collegium Pharmaceuticals Inc (NASDAQ: COLL) shares jumped more than 13 percent on Thursday after health insurance giant CIGNA Corporation (NYSE: CI) announced it will be discontinuing coverage of Purdue Pharma’s popular opioid painkiller OxyContin. Citing safety concerns about opioid abuse...
-
The FDA's Historic Caution On Abuse Deterrent Labeling
Friday, November 25, 2016 - 12:18pm | 408Before the market open on Friday, IntelliPharmaCeutics Intl Inc (USA) (NASDAQ: IPCI)reported its NDA submission for its abuse-deterrent Rexista (oxycodone hydrochloride) extended release tablets designed in 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg and 80 mg strengths. "The NDA submission of...
-
Trading Alert: Collegium Pharmaceuticals May See Increased Activity Thursday
Wednesday, August 17, 2016 - 3:49pm | 373Biotech traders may want to keep an eye on Collegium Pharmaceuticals Inc (NASDAQ: COLL) on Thursday morning, as the stock may see increased activity due to an expert networking call between investors and an expert discussing the company's drug Xtampza ER. On April 27, the FDA approved Collegium's...
-
Dow Breaks Four-Day Losing Streak As Calm Restores Last Week's Jittery Market
Monday, August 4, 2014 - 4:57pm | 2610U.S. stocks rallied to start the week on a positive note. Investors are looking for bullish signs that can erase last weeks declines, as the S&P 500 had its largest weekly drop since 2012 and the Volatility Index surged more than 30 percent. Portugal's Central Bank plans to spend 4.9...
-
Top Percentage Gainers and Losers as of 2pm 6/20/11
Monday, June 20, 2011 - 2:00pm | 842Best 1) Harbin Electric (NASDAQ: HRBN): Shares of Harbin Electric are currently trading up 60% from Friday's close to $13.42. The company announced that it has agreed to be acquired for $24 per share in cash by Tech Full Electric, which is indirectly owned by the current Harbin CEO and Chairman,...